Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities

Eleanor C. Smith, Bryan T Mott, Emily Douglas, Stephen B. Tatter, Kounosuke Watabe · 2024

Read Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities by Eleanor C. Smith, Bryan T Mott, Emily Douglas, Stephen B. Tatter, Kounosuke Watabe (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11607011.txt.

Description

Eleanor Smith and co-authors review immune therapy for cancer spread to the leptomeninges in a 2024 paper. This late-stage spread seeds cancer in the fluid and linings around the brain and cord. Outlook stays very poor, and no standard care exists. Many trials shut these patients out, so data are thin.

The review weighs systemic immune drugs, drugs given into the spinal fluid, and combined plans. Current gains look limited across the board. The immune setting of the leptomeningeal space may hold the key to better picks. Fresh work on that setting is charted. The authors call for trials that include these patients by design.

Catalog record

CREATOREleanor C. Smith, Bryan T Mott, Emily Douglas, Stephen B. Tatter, Kounosuke Watabe
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11607011

Browse the full library · About the Tower of Babel